Neuropharmacological activities of ethanol leaf extract of Cussonia barteri Seeman (Araliaceae) in laboratory animals
Abstract
The anticonvulsant studies on Cussonia barteri Seeman (Araliaceae) were carried out using maximal electroshock test (MEST), pentylenetetrazole and strychnine-induced seizures model in chicks and mice. In addition, sedative and anxiolytic effect of the extract was evaluated using diazepam-induced sleeping time, hole-board, beam walk assay and open field test in mice. The extract was also evaluated for acute toxicity. The oral and intraperitoneal LD50 of the extract was estimated to be greater than 5,000 mg/kg and 2, 154.1 mg/kg body weight respectively. The extract did not protect the chicks against maximal electroshock seizure; neither did it shorten the mean recovery time. The extract produced 66.67% and 83.33% protection against strychnine and pentylenetetrazole induced seizures respectively at the highest dose (400 mg/kg) tested. The extract decreases the number of head dips in hole-board test, suggesting its sedative property, which was confirmed by the ability of extract to prolonged diazepam sleeping time. The extract did not significantly increase the time spent on the beam but at the highest dose tested significantly increased the number of foot slips, an index of motor coordination deficit. The extract insignificantly decreased number of rearing, Total Square and Central Square crossed in an open field test. These results suggest that the extract may contain compound(s) that may be beneficial in the management of absence or myoclonic seizures.
Keywords: Cussonia barteri; Epilepsy; Seizure; Sedative; Anxiolytic
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
